See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Natural Disasters
Baseball
Social Media
Democratic Party
Republican Party
Education
Senate
Tariffs
US Politics
Artificial Intelligence
Donald Trump
Soccer
Published • loading... • Updated

Temasek’s 65 Equity makes Europe foray with Swiss pharma merger

Summary by The Straits Times
It is financing Healthcare Advanced Synthesis’ acquisition of Cerbios-Pharma and taking a 40% stake in the merged entity.

2 Articles

All
Left
Center
Right
1
The Straits TimesThe Straits Times
Lean Right

Temasek’s 65 Equity makes Europe foray with Swiss pharma merger

It is financing Healthcare Advanced Synthesis’ acquisition of Cerbios-Pharma and taking a 40% stake in the merged entity.

·Singapore
Read Full Article
Business TimesBusiness Times

Temasek-backed 65 Equity Partners makes Europe foray with Swiss pharma merger

Asset manager 65 Equity Partners is backing Swiss pharmaceutical ingredient maker Healthcare Advanced Synthesis’ (HAS) acquisition of Cerbios-Pharma, marking its first deal in Europe.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Business Times broke the news in on Sunday, March 30, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Business

Business

Switzerland

Switzerland

Switzerland Economy

Switzerland Economy

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal